What tablet strengths and dosing regimens are recommended for Klonopin (clonazepam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Klonopin Tablet Strengths and Dosing

Klonopin tablets are available in three strengths: 0.5 mg, 1 mg, and 2 mg, with dosing regimens varying significantly based on the indication—seizure disorders require initial doses of 1.5 mg/day divided into three doses, while panic disorder starts at 0.25 mg twice daily. 1

Available Tablet Formulations

Klonopin is manufactured in the following tablet strengths 1:

  • 0.5 mg (orange, scored tablets with K-shaped perforation)
  • 1 mg (blue, unscored tablets with K-shaped perforation)
  • 2 mg (white, unscored tablets with K-shaped perforation)

All tablets should be swallowed whole with water.

Dosing by Indication

Seizure Disorders

Adults:

  • Initial dose: 1.5 mg/day divided into three doses (not to exceed this starting dose)
  • Titration: Increase by 0.5-1 mg every 3 days until seizures are controlled or side effects occur
  • Maximum dose: 20 mg/day
  • Maintenance dosing must be individualized based on response 1

Pediatric patients (up to 10 years or 30 kg):

  • Initial dose: 0.01-0.03 mg/kg/day (not exceeding 0.05 mg/kg/day) in 2-3 divided doses
  • Titration: Increase by no more than 0.25-0.5 mg every third day
  • Target maintenance: 0.1-0.2 mg/kg/day in three equal doses
  • Give largest dose before bedtime if doses cannot be equally divided 1

Geriatric patients:

  • Start on low doses with close observation
  • No specific clinical trial data available for patients ≥65 years 1

Panic Disorder

Adults:

  • Initial dose: 0.25 mg twice daily
  • Target dose: 1 mg/day (optimal effect demonstrated in fixed-dose studies)
  • Titration: Increase to target after 3 days; may further increase by 0.125-0.25 mg twice daily every 3 days if needed
  • Maximum dose: 4 mg/day (though doses of 2-4 mg/day were less effective and had more adverse effects than 1 mg/day in clinical trials)
  • Consider single bedtime dosing to reduce daytime somnolence 1

The 1 mg/day dose offers the best balance of efficacy and tolerability for panic disorder 2, 3. Higher doses (2-4 mg/day) showed no additional benefit and increased adverse effects 2.

REM Sleep Behavior Disorder (Off-Label)

Standard dosing:

  • Initial dose: 0.25-0.5 mg at bedtime
  • Typical effective range: 0.5-2 mg nightly (taken 30 minutes before bed)
  • Maximum reported: Up to 4 mg/day in some cases
  • Women may require higher doses (mean 1.4 mg) than men (mean 0.68 mg) 4

Clonazepam demonstrates 90% efficacy in controlling REM sleep behavior disorder, with clinical improvement typically observed within the first week 5, 4. The medication can be taken 1-2 hours before bedtime if morning drowsiness or sleep onset insomnia occurs 5.

Important Dosing Considerations

Discontinuation

Always taper gradually to reduce withdrawal risk, increased seizure frequency, and status epilepticus 1:

  • For panic disorder: Decrease by 0.125 mg twice daily every 3 days 1
  • If withdrawal reactions develop, pause taper or increase to previous dose level, then decrease more slowly 1

Special Populations

  • Elderly/debilitated patients: Start with lower doses due to increased risk of sedation, falls, confusion, and cognitive impairment 4, 6, 4
  • Renal impairment: No specific dose adjustments provided in labeling, but use caution
  • Hepatic disease: Use with caution and oversight 4

Common Pitfalls

  • Underdosing in seizure disorders: The initial 1.5 mg/day is often necessary; starting too low may result in inadequate seizure control
  • Overdosing in panic disorder: Doses above 1 mg/day rarely provide additional benefit and increase adverse effects 2
  • Abrupt discontinuation: Always taper to avoid withdrawal and rebound symptoms
  • Use in sleep apnea: Clonazepam can worsen obstructive sleep apnea at doses of 0.5-1 mg 4
  • Polypharmacy in elderly: Particularly problematic when combined with neurodegenerative disease; increases fall risk and cognitive impairment 6, 4

Drug Interactions

When adding clonazepam to existing anticonvulsant regimens, anticipate increased CNS depressant effects 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.